Health Ministry bans 156  Fixed Dose Combination Drugs (FDC) | Current Affairs | Vision IAS
News Today Logo

    Health Ministry bans 156  Fixed Dose Combination Drugs (FDC)

    Posted 23 Aug 2024

    2 min read

    These were banned due to the concerns about their irrationality and potential risks to human health with safer alternatives available.

    • Previously, 344 combination drugs in 2016 and 14 FDCs in 2023 were also banned.

    About FDC

    • These are the combination of two or more Active Pharmaceutical Ingredients (APIs) in fixed ratios and also known as 'cocktail drugs'.
      • APIs are the biologically active component of a drug product that produces the intended effects.

    Benefits of the FDC

    • Targeting multiple disease pathways: Leading to improved response rates and rapid actions.
    • Minimises pill burden: Fewer pills ensures greater adherence and better outcomes. Eg, a single pill for fever, cough, and pain can foster better compliance. 
    • Beneficial for treating chronic illness: Like TB, diabetes, etc.
    • It has a pharmacokinetic advantage.
      • Pharmacokinetics is defined as the study of absorption, distribution, metabolism, and excretion of drugs by the body.

    Concerns with FDC

    • Physiological or Chemical reaction: Opposing/Antagonistic combination can lead to enhanced toxicity, reduced efficacy, etc. 
    • Decreased Shelf life: In case of chemical incompatibility between the two drugs. 
    • Growing antibiotic resistance: Sale of unapproved or banned FDCs containing  antibiotics. 

    Rules Governing FDC in India

    • Appendix VI of Schedule Y to Drugs & Cosmetics Rules 1945, specifies the requirements for approval of various categories of FDCs.
    • Drug and Cosmetic (Amendment) Act, 2008, section 26A gives power to the Central Government to prohibit manufacture, etc., of drugs and cosmetics in public interest.
    • Tags :
    • Active Pharmaceutical Ingredient (API)
    • Fixed Dose Combination
    • Drug and Cosmetic Rules, 1945
    Watch News Today
    Subscribe for Premium Features